Detection and Diagnosis of Retinoblastoma: Can Mobile Devices Be the Next Step Toward Early Intervention?

Abdur Rahman Jabir1, Haniah A Zaheer2, Myra A Zaheer3

  • 1School of Medicine, Northeast Ohio Medical University, Rootstown, USA.

Cureus
|November 16, 2022
PubMed

Insights

Mobile devices show promise for early retinoblastoma (RB) detection in children. Further research is needed to confirm their effectiveness for healthcare providers and parents in diagnosing this common pediatric eye cancer.

Area of Science:

  • Ophthalmology
  • Pediatric Oncology
  • Medical Technology

Background:

  • Retinoblastoma (RB) is a prevalent pediatric intraocular cancer.
  • Clinical diagnosis can be delayed due to factors like small tumor size or missed appointments.
  • Mobile devices offer a potential new tool for screening and detection.

Purpose of the Study:

  • To systematically review the literature on mobile device use for early retinoblastoma detection.
  • To assess the potential role of mobile devices for healthcare providers and parents.

Main Methods:

  • A comprehensive literature search was performed using PubMed, CINAHL, and Web of Science.
  • Ten studies were included in the final systematic review analysis.

Main Results:

  • The existing literature on mobile device use for RB detection is still limited.
  • Further research is required to establish the efficacy of mobile devices in diagnosing retinoblastoma.

Conclusions:

  • Mobile devices present a novel approach for retinoblastoma screening and detection.
  • More research is necessary to validate their role in clinical practice and parental use.